Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study.
Journal: EClinicalMedicine
Published: October 17, 2022
Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer.
Journal: The oncologist
Published: December 06, 2020
Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies.
Journal: Cancers
Published: July 10, 2020
The Impact of Prolonged Chemotherapy to Surgery Interval and Neoadjuvant Radiotherapy on Pathological Complete Response and Overall Survival in Pancreatic Cancer Patients.
Journal: Clinical Medicine Insights. Oncology
Published: July 14, 2019
Correction: Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral env RNA in Pancreatic Cancer Cells Decreases Cell Proliferation and Tumor Growth.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 03, 2019
A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer.
Journal: BMC cancer
Published: February 28, 2019
Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral env RNA in Pancreatic Cancer Cells Decreases Cell Proliferation and Tumor Growth.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 03, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026